Form 8.3 – Octopus Investments – Clinigen Group plc – GlobeNewswire

December 20, 2021 by No Comments

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1.        KEY INFORMATION

 

<…….

Source: https://www.globenewswire.com/news-release/2021/12/20/2355211/0/en/Form-8-3-Octopus-Investments-Clinigen-Group-plc.html

Tags:

Leave a Comment

Your email address will not be published. Required fields are marked *

(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD
(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):

        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 
(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:

        Use a separate form for each offeror/offeree

Clinigen Group plc
(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e)        Date position held/dealing undertaken:

        For an opening position disclosure, state the latest practicable date prior to the disclosure

17/12/2021